148 related articles for article (PubMed ID: 1553349)
1. Bioavailability of leuprolide acetate following nasal and inhalation delivery to rats and healthy humans.
Adjei A; Sundberg D; Miller J; Chun A
Pharm Res; 1992 Feb; 9(2):244-9. PubMed ID: 1553349
[TBL] [Abstract][Full Text] [Related]
2. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization.
Shahnaz G; Vetter A; Barthelmes J; Rahmat D; Laffleur F; Iqbal J; Perera G; Schlocker W; Dünnhaput S; Augustijns P; Bernkop-Schnürch A
Int J Pharm; 2012 May; 428(1-2):164-70. PubMed ID: 22421322
[TBL] [Abstract][Full Text] [Related]
3. Effect of formulation adjuvants on gastrointestinal absorption of leuprolide acetate.
Adjei A; Love S; Johnson E; Diaz G; Greer J; Haviv F; Bush E
J Drug Target; 1993; 1(3):251-8. PubMed ID: 8069567
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary peptide delivery: effect of taste-masking excipients on leuprolide suspension metered-dose inhalers.
Zheng JY; Fulu MY; Lee DY; Barber TE; Adjei AL
Pharm Dev Technol; 2001 Nov; 6(4):521-30. PubMed ID: 11775953
[TBL] [Abstract][Full Text] [Related]
5. Fractional contribution of lung, nasal and gastrointestinal absorption to the systemic level following nose-only aerosol exposure in rats: a case study of 3.7- micro m fluorescein aerosols.
Sakagami M; Kinoshita W; Sakon K; Makino Y
Arch Toxicol; 2003 Jun; 77(6):321-9. PubMed ID: 12799771
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary delivery of peptide drugs: effect of particle size on bioavailability of leuprolide acetate in healthy male volunteers.
Adjei A; Garren J
Pharm Res; 1990 Jun; 7(6):565-9. PubMed ID: 2114618
[TBL] [Abstract][Full Text] [Related]
7. Preliminary investigation of the nasal delivery of liposomal leuprorelin acetate for contraception in rats.
Shahiwala A; Misra A
J Pharm Pharmacol; 2006 Jan; 58(1):19-26. PubMed ID: 16393460
[TBL] [Abstract][Full Text] [Related]
8. Sublingual absorption of leuprolide: comparison between human and animal models.
Qiu Y; Johnson HW; Reiland TL; Lu MY
Int J Pharm; 1999 Mar; 179(1):27-36. PubMed ID: 10053199
[TBL] [Abstract][Full Text] [Related]
9. Serum concentration patterns of an LHRH agonist, gonadotrophins and sex steroids after subcutaneous, vaginal, rectal and nasal administration of the agonist to pregnant rats.
Yamazaki I
J Reprod Fertil; 1984 Sep; 72(1):129-36. PubMed ID: 6433008
[TBL] [Abstract][Full Text] [Related]
10. Leuprolide acetate: pharmaceutical use and delivery potentials.
Teutonico D; Montanari S; Ponchel G
Expert Opin Drug Deliv; 2012 Mar; 9(3):343-54. PubMed ID: 22335366
[TBL] [Abstract][Full Text] [Related]
11. Vaginal absorption of a potent luteinizing hormone-releasing hormone analog (leuprolide) in rats I: absorption by various routes and absorption enhancement.
Okada H; Yamazaki I; Ogawa Y; Hirai S; Yashiki T; Mima H
J Pharm Sci; 1982 Dec; 71(12):1367-71. PubMed ID: 6818337
[TBL] [Abstract][Full Text] [Related]
12. Morphine pharmacokinetics after pulmonary administration from a novel aerosol delivery system.
Ward ME; Woodhouse A; Mather LE; Farr SJ; Okikawa JK; Lloyd P; Schuster JA; Rubsamen RM
Clin Pharmacol Ther; 1997 Dec; 62(6):596-609. PubMed ID: 9433388
[TBL] [Abstract][Full Text] [Related]
13. Toxicokinetics and bioavailability of paraquat in rats following different routes of administration.
Chui YC; Poon G; Law F
Toxicol Ind Health; 1988 Jun; 4(2):203-19. PubMed ID: 3176035
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic behavior of peramivir in the plasma and lungs of rats after trans-nasal aerosol inhalation and intravenous injection.
Ding H; Wu S; Dai X; Gao Y; Niu Y; Fang N; Song Y; Zhang M; Wang X; Chen T; Zhang G; Wu J; Li Y; Han J
Biomed Pharmacother; 2020 Sep; 129():110464. PubMed ID: 32768954
[TBL] [Abstract][Full Text] [Related]
15. A Randomized Trial Comparing the Pharmacokinetics, Safety, and Tolerability of DFN-02, an Intranasal Sumatriptan Spray Containing a Permeation Enhancer, With Intranasal and Subcutaneous Sumatriptan in Healthy Adults.
Munjal S; Gautam A; Offman E; Brand-Schieber E; Allenby K; Fisher DM
Headache; 2016 Oct; 56(9):1455-1465. PubMed ID: 27613076
[TBL] [Abstract][Full Text] [Related]
16. Regional differences in bioavailability of an opioid tetrapeptide in vivo in rats after administration to the respiratory tract.
Krondahl E; Tronde A; Eirefelt S; Forsmo-Bruce H; Ekström G; Bengtsson UH; Lennernäs H
Peptides; 2002 Mar; 23(3):479-88. PubMed ID: 11835997
[TBL] [Abstract][Full Text] [Related]
17. Incidence of low bioavailability of leuprolide acetate after percutaneous administration to rats by dissolving microneedles.
Ito Y; Murano H; Hamasaki N; Fukushima K; Takada K
Int J Pharm; 2011 Apr; 407(1-2):126-31. PubMed ID: 21277965
[TBL] [Abstract][Full Text] [Related]
18. Validation of intratracheal instillation as an alternative for aerosol inhalation toxicity testing.
Sabaitis CP; Leong BK; Rop DA; Aaron CS
J Appl Toxicol; 1999; 19(2):133-40. PubMed ID: 10215185
[TBL] [Abstract][Full Text] [Related]
19. Vaginal absorption of a potent luteinizing hormone-releasing hormone analogue (leuprolide) in rats. IV: Evaluation of the vaginal absorption and gonadotropin responses by radioimmunoassay.
Okada H; Yamazaki I; Yashiki T; Shimamoto T; Mima H
J Pharm Sci; 1984 Mar; 73(3):298-302. PubMed ID: 6425491
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary delivery of a dopamine D-1 agonist, ABT-431, in dogs and humans.
Zheng Y; Marsh KC; Bertz RJ; El-Shourbagy T; Adjei AL
Int J Pharm; 1999 Nov; 191(2):131-40. PubMed ID: 10564839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
